Interdisciplinary

Gold Nanoparticle Cancer Treatment Paper Pulled Over Research Flaws

How the science connects

NanotechnologyCancer treatmentPhotothermal therapy

AI Insight

This is a retraction notice, not a research article. The PLOS ONE editors have retracted a previously published paper that described the synthesis of a nanocomposite combining poly(histidine-co-phenylalanine) with gold nanoparticles (PHF@AuNPs) for use in near-infrared light-triggered photodynamic therapy. The original article has been withdrawn from the scientific record, meaning its findings are no longer considered valid or reliable.


Retractions are critical for maintaining scientific integrity and preventing the propagation of unreliable findings in medical research. This retraction alerts researchers and clinicians working on photodynamic cancer therapies that the reported synthesis method and therapeutic applications should not be relied upon for further research or clinical development.


Understand the Science

Nanotechnology 16 articles Explore Concept → Cancer treatment Concept coming soon Photothermal therapy Concept coming soon

by The PLOS One Editors

Source: Retraction: One step synthesis of ultrafine PHF@AuNPs nanocomposite and its application in NIR triggered photodynamic therapy